HLHannah L. Litwak

Hannah L. Litwak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hannah L. Litwak has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Allen Bateman

    University of Wisconsin-Madison Wisconsin State Laboratory of Hygiene

    2 shared publications
  • Brian Emery

    National Center for Immunization and Respiratory Disease, US Centers for Disease Control and Prevention Atlanta Georgia USA

    2 shared publications
  • Caelin Cubenas

    National Center for Immunization and Respiratory Disease, US Centers for Disease Control and Prevention Atlanta Georgia USA

    2 shared publications
  • Carlos M. Perez

    Wisconsin Division of Public Health Wisconsin Department of Health Services Madison Wisconsin USA

    2 shared publications
  • Cria O. Gregory

    National Center for Immunization and Respiratory Disease, US Centers for Disease Control and Prevention Atlanta Georgia USA

    2 shared publications
  • Kyley Anhalt

    Wisconsin State Laboratory of Hygiene Madsion Wisconsin USA

    2 shared publications

Latest Publications

  • Open Access

    Diversity of Rhinovirus and Enterovirus Infections Among Pediatric Patients Hospitalized in Wisconsin, 2022–2023

    by Hannah L. Litwak, Carlos M. Perez, Allen Bateman, Kyley Anhalt, Xiaoyan Lu, Shannon Rogers, Brian Emery, Terry Fei Fan Ng, Caelin Cubenas, Cria O. Gregory, et al.

    Severe rhinovirus (RV)/enterovirus (EV) respiratory infections in pediatric patients increased in the US during 2022–2023. This study aimed to characterize RV/EV genetic diversity among hospitalized children in Wisconsin and describe demographic and clinical factors of patients by RV/EV type. During September 2022–April 2023, five Wisconsin pediatric hospitals submitted five RV/EV‐positive specimens weekly to CDC. Viral typing was performed using partial viral protein (VP) 4/VP2 (RV) and VP1 (EV) sequencing. Wisconsin Department of Health Services abstracted demographic, comorbid condition, and hospitalization course information from patient medical records. Ninety‐six patients were included in this investigation. RV‐C ( n = 40, 42%) and RV‐A ( n = 31, 32%) were the most frequently detected species, with 46 RV and 5 EV types identified. The median age was 2.5 (IQR: 0.7–5.5) years. Seventy‐one (74%) children had at least one comorbid condition. Asthma was more common among children with RV‐C infections ( n = 12, 30%) compared with other RVs ( n = 3, 9%) ( p = 0.02). RV‐A and RV‐C were important contributors to severe pediatric respiratory infection in Wisconsin. Molecular typing showed virus divergence typically observed during season‐long investigations. Year‐round molecular characterization is needed to better understand the contribution of RV/EV types to severe pediatric respiratory illness.

  • Open Access

    Diversity of Rhinovirus and Enterovirus Infections Among Pediatric Patients Hospitalized in Wisconsin, 2022-2023

    by Hannah L. Litwak, Carlos M. Perez, Allen Bateman, Kyley Anhalt, Xiaoyan Lu, Shannon Rogers, Brian Emery, T Ng, Caelin Cubenas, Cria O. Gregory, et al.

    Severe rhinovirus (RV)/enterovirus (EV) respiratory infections in pediatric patients increased in the US during 2022-2023. This study aimed to characterize RV/EV genetic diversity among hospitalized children in Wisconsin and describe demographic and clinical factors of patients by RV/EV type. During September 2022–April 2023, five Wisconsin pediatric hospitals submitted five RV/EV-positive specimens weekly to CDC. Viral typing was performed using partial viral protein (VP) 4/VP2 (RV) and VP1 (EV) sequencing. Wisconsin Department of Health Services abstracted demographic, comorbid condition, and hospitalization course information from patient medical records. Ninety-six patients were included in this investigation. RV-C (n=40, 42%) and RV-A (n=31, 32%) were the most frequently detected species, with 46 RV and 5 EV types identified. The median age was 2.5 (IQR: 0.7-5.5) years. Seventy-one (74%) children had at least one comorbid condition. Asthma was more common among children with RV-C infections (n=12, 30%) compared with other RVs (n=3, 9%) (p=0.02). RV-A and RV-C were important contributors to severe pediatric respiratory infection in Wisconsin. Molecular typing showed virus divergence typically observed during season-long investigations. Year-round molecular characterization is needed to better understand the contribution of RV/EV types to severe pediatric respiratory illness.